Loading…
LEQVIO (inclisiran) is a prescription cholesterol-lowering injection that reduces bad LDL cholesterol by approximately 50% in adults with atherosclerotic cardiovascular disease. After two initial doses, patients receive it only twice a year, on top of maximally tolerated statin therapy.
AI named Leqvio in October 2025.